Physician profile

Mina Fam

Urology · Brick, NJ

NPI 1659661338

$35,407.58

in general payments reported to CMS, 2019-2025

51 companies · $4,819 in 2025

The $4,819 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,326.37
Consulting Fee$3,315.00
Education$2,700.00
Travel and Lodging$1,658.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $21,365.72 2019-2023 Da Vinci Surgical System
Baxter Healthcare $6,631.45 2020-2025 Floseal, Tisseel
Biotissue Holdings INC. $1,577.10 2024
Edap Technomed INC $784.04 2024-2025
Procept Biorobotics Corporation $515.41 2022-2025 Aquabeam System
Boston Scientific Corporation $345.35 2019-2025 Lithovue
Teleflex LLC $302.09 2021-2025 Barrigel
Medtronic, INC. $282.49 2022-2025 Interstim
Pfizer INC. $273.03 2019-2025
Neotract INC. $243.04 2019
Coloplast Corp $240.77 2019-2025 Speedicath
Dendreon Pharmaceuticals LLC $233.48 2019-2024 Provenge
Calyxo, INC. $204.68 2025 Cvac Aspiration System
Antares Pharma, INC. $194.36 2020-2025 Xyosted, Nocdurna, Tlando
Janssen Biotech, INC. $174.06 2019-2025 Erleada
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $147.04 2019-2024 Xtandi
Becton, Dickinson and Company $145.30 2019
Bayer Healthcare Pharmaceuticals INC. $138.51 2019-2024
Merck Sharp & Dohme LLC $131.55 2022-2025 Keytruda, Lynparza, Welireg
Myovant Sciences INC. $126.28 2021-2022
Angiodynamics, INC. $112.47 2021
Davol INC. $104.36 2023 Channel Drain
Ferring Pharmaceuticals INC. $102.97 2024-2025 Adstiladrin
Sumitomo Pharma America, INC. $102.13 2023-2025 Orgovyx
Telix Pharmaceuticals $86.72 2024-2025 Illuccix
Abbvie INC. $86.34 2024-2025
Verity Pharmaceuticals INC. $84.15 2023-2025 Trelstar, Tlando
Dentsply Ih Ab $68.58 2023-2025 Lofric, Lofric
Blue Earth Diagnostics $58.15 2019-2020
Accord Healthcare, INC. $50.30 2022-2024
Myriad Genetic Laboratories, INC. $45.19 2021-2024 Prolaris
180 Medical, INC. $41.48 2023-2024
Alnylam Pharmaceuticals INC. $38.91 2021
Olympus America INC. $33.17 2021
Novartis Pharmaceuticals Corporation $30.75 2024-2025
Urogen Pharma, INC. $29.91 2023 Jelmyto
Progenics Pharmaceuticals, INC. $27.99 2023 Pylarify
Profound Medical Corp. $25.33 2025 Tulsa-Pro
Bioprotect Medical, INC. $24.88 2025 Bioprotect Balloon Implant System
Musculoskeletal Transplant Foundation INC. $24.58 2019
Abc Home Medical Supply, INC. $20.91 2025
Photocure INC $19.15 2025 Cysview
Medtronic USA, INC. $18.20 2019
Astrazeneca Pharmaceuticals LP $16.53 2025
Ethicon US, LLC $15.09 2019
Dentsply Ih INC. $14.70 2021
Clarus Therapeutics INC. $14.52 2021
Urovant Sciences INC $14.49 2022
Immunitybio, INC. $13.63 2025
Tolmar Pharmaceuticals, INC. $13.47 2019
Endo Pharmaceuticals INC. $12.78 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mina Fam

$35,407.58

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $4,819 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/2786877/mina-fam

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.